Overview

Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
1994-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the relative bioavailability of Nadolol (1 x 80 mg) tablets under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Nadolol